These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 808105)

  • 21. [Alprenolol and alphamethyl-dopa in untreated cases of essential hypertension--a comparison].
    Bergstrand RH; Vedin JA; Wilhelmsson CE
    Lakartidningen; 1973 Aug; 70(33):2817-20. PubMed ID: 4597664
    [No Abstract]   [Full Text] [Related]  

  • 22. Deaths and non-fatal reinfarctions during two years' follow-up.
    Wihelmsson C; Vedin A; Wilhelmsen L; Tibblin G; Werkö L; Wedel H
    Acta Med Scand Suppl; 1975; 575():19-24. PubMed ID: 1098398
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical impact of local implementation of agreed guidelines for the management of patients with acute myocardial infarction.
    Badano L; Cassin M; Solinas L; Burelli C; Macor F; Zanuttini D
    G Ital Cardiol; 1999 Jan; 29(1):39-47. PubMed ID: 9987046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of alprenolol in the secondary prevention of myocardial infarction.
    Jürgensen HJ
    Acta Med Scand Suppl; 1984; 680():59-64. PubMed ID: 6375282
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of alprenolol on serum myoglobin levels in acute myocardial infarction.
    Pedersen F; Rasmussen SL; Kølendorf K; Christiansen E
    Scand J Clin Lab Invest; 1984 Nov; 44(7):649-54. PubMed ID: 6531653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind trial of lidocaine in acute myocardial infarction.
    Valentine PA; Frew JL; Mashford ML; Sloman JG
    Med J Aust; 1973 Aug; 2(1):Suppl:43-5. PubMed ID: 4598560
    [No Abstract]   [Full Text] [Related]  

  • 27. Lidocaine in the prevention of sudden death in the pre-hospital phase of acute infarction. A double-blind study.
    Valentine PA; Frew JL; Mashford ML; Sloman JG
    N Engl J Med; 1974 Dec; 291(25):1327-31. PubMed ID: 4610393
    [No Abstract]   [Full Text] [Related]  

  • 28. The Timolol Myocardial Infarction Study: an evaluation of selected variables.
    Rodda BE
    Circulation; 1983 Jun; 67(6 Pt 2):I101-6. PubMed ID: 6342836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Triamterene in acute myocardial infarction. Prospective double-blind study of the effect of triamterene on the frequency of arrhythmia and mortality in acute myocardial infarction].
    Bruun L; Czartoryski A
    Ugeskr Laeger; 1974 Dec; 136(49):2745-8. PubMed ID: 4614515
    [No Abstract]   [Full Text] [Related]  

  • 30. Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
    Meier JJ; Deifuss S; Klamann A; Schmiegel W; Nauck MA;
    Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):344-50. PubMed ID: 14520601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison between alprenolol in tablet form (Aptin) and in "sustained release" form (Aptin Durules) in angina pectoris].
    Lorentzen F; Jorgensen P; Nielsen E; Nyberg G; Hvidt S
    Ugeskr Laeger; 1973 Jul; 135(27):1431-8. PubMed ID: 4585750
    [No Abstract]   [Full Text] [Related]  

  • 32. Beta-adrenergic blocking agents in prevention of sudden death.
    Chamberlain DA
    Adv Cardiol; 1978; 25():196-205. PubMed ID: 30260
    [No Abstract]   [Full Text] [Related]  

  • 33. [Anticoagulant therapy of acute myocardial infarct and its sequelae].
    Sorensen OH; Friis T; Wjorgensen AW; Jorgensen MB; Bnissen NI
    Ugeskr Laeger; 1968 Feb; 130(8):318-27. PubMed ID: 5676619
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term therapy of ischaemic heart disease.
    Dewar HA
    Arzneimittelforschung; 1972 Oct; 22(10):1835-40. PubMed ID: 4630017
    [No Abstract]   [Full Text] [Related]  

  • 35. Alprenolol in angina pectoris. A comparative study of the tablet form and slow-release formulation.
    Lorentzen F; Jorgensen P; Nielsen E; Nyberg G; Hvidt S
    Med J Aust; 1975 Oct; 2(17):668-73. PubMed ID: 1107769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic effect of alprenolol on ventricular tachyarrhythmias during the in-patient phase of acute myocardial infarction.
    Pedersen F; Rasmussen SL
    Acta Med Scand Suppl; 1984; 680():34-9. PubMed ID: 6375278
    [No Abstract]   [Full Text] [Related]  

  • 37. Short and long-term outcome in diabetic patients with acute myocardial infarction in the invasive era.
    Hansen HH; Joensen AM; Riahi S; Malczynski J; Mølenberg D; Ravkilde J
    Scand Cardiovasc J; 2007 Jan; 41(1):19-24. PubMed ID: 17365973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laboratory analyses during two years' treatment with alprenolol in patients with myocardial infarction.
    Wilhelmsson C; Vedin A
    Acta Med Scand Suppl; 1975; 575():31-5. PubMed ID: 168738
    [No Abstract]   [Full Text] [Related]  

  • 39. Angina pectoris, hypertension, decompensation and return to work during two years' follow-up.
    Vedin A; Wilhelmson C
    Acta Med Scand Suppl; 1975; 575():25-30. PubMed ID: 1098399
    [No Abstract]   [Full Text] [Related]  

  • 40. Limitation of myocardial infarct size in patients less than 66 years treated with alprenolol.
    Jürgensen JH; Frederiksen J; Hansen DA; Pedersen-Bjergaard O
    Br Heart J; 1981 May; 45(5):583-8. PubMed ID: 7016150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.